BTAI
Bioxcel Therapeutics·NASDAQ
--
--(--)
--
--(--)
BTAI fundamentals
Bioxcel Therapeutics (BTAI) released its earnings on Aug 12, 2025: revenue was 120.00K (YoY -89.13%), missed estimates; EPS was -2.45 (YoY +27.08%), missed estimates.
Revenue / YoY
120.00K
-89.13%
EPS / YoY
-2.45
+27.08%
Report date
Aug 12, 2025
Earnings Call
7:00 AM on Aug 12, 2025
Meeting link.EPS
Actual | -12.64 | -16.96 | -17.12 | -13.92 | -17.28 | -17.76 | -15.36 | -14.88 | -17.92 | -21.6 | -23.84 | -31.2 | -29.44 | -29.28 | -27.52 | -12.16 | -13.92 | -3.36 | -5.12 | -3.57 | -1.5 | -2.45 | ||||||||
Forecast | -9.2264 | -12.32 | -12.68 | -14.4282 | -15.238 | -17.1514 | -16.5812 | -17.046 | -17.56 | -19.2042 | -20.9762 | -22.7551 | -25.898 | -27.8933 | -20.3823 | -14.667 | -10.799 | -11.401 | -8.0887 | -6.0441 | -2.72 | -1.8575 | ||||||||
Surprise | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -37.00% | -37.66% | -35.02% | +3.52% | -13.40% | -3.55% | +7.36% | +12.71% | -2.05% | -12.48% | -13.65% | -37.11% | -13.68% | -4.97% | -35.02% | +17.09% | -28.90% | +70.53% | +36.70% | +40.93% | +44.85% | -31.90% |
Revenue
Actual | -- | -- | -- | -- | -- | -- | -- | -- | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 137.00K | 238.00K | 206.00K | 457.00K | 341.00K | 376.00K | 582.00K | 1.10M | 214.00K | 366.00K | 168.00K | 120.00K |
Forecast | -- | -- | -- | -- | -- | -- | -- | -- | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 125.00K | 0 | 1.00M | 1.08M | 389.00K | 453.89K | 626.00K | 742.86K | 450.00K | 762.50K | 1.33M | 309.67K | 300.00K | 175.00K |
Surprise | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -100.00% | 0.00% | -86.37% | -77.96% | -47.04% | +0.69% | -45.53% | -49.38% | +29.33% | +44.79% | -83.88% | +18.19% | -44.00% | -31.43% |
Earnings Call
You can ask Aime
What is the revenue and EPS growth rate for Bioxcel Therapeutics year over year?What factors drove the changes in Bioxcel Therapeutics's revenue and profit?Did Bioxcel Therapeutics beat or miss consensus estimates last quarter?What guidance did Bioxcel Therapeutics's management provide for the next earnings period?What is the market's earnings forecast for Bioxcel Therapeutics next quarter?What is Bioxcel Therapeutics's gross profit margin?What does Bioxcel Therapeutics do and what are its main business segments?What were the key takeaways from Bioxcel Therapeutics's earnings call?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
